Project

Development of alphaVBeta3 nanobodies as novel cancer therapy

Duration
01 January 2013 → 31 December 2016
Funding
Funding by bilateral agreement (private and foundations)
Research disciplines
  • Medical and health sciences
    • Immunology
    • Immunology
    • Immunology
Keywords
cancer therapy
 
Project description

In this project, we investigate whether specific antibodies against an integrin have anticancer effects.